NO20005332L - 1,6-GPS-(6-O-α-D-glukopyranosyl-D-sorbit) og 1,1-GPM-(1-O-α-D-glukopyranosyl-D-mannit)-holdig sukkeralkoholblanding for bruk som terapeutisk aktivt stoff samt legemiddel inneholdende nevnte blanding - Google Patents

1,6-GPS-(6-O-α-D-glukopyranosyl-D-sorbit) og 1,1-GPM-(1-O-α-D-glukopyranosyl-D-mannit)-holdig sukkeralkoholblanding for bruk som terapeutisk aktivt stoff samt legemiddel inneholdende nevnte blanding

Info

Publication number
NO20005332L
NO20005332L NO20005332A NO20005332A NO20005332L NO 20005332 L NO20005332 L NO 20005332L NO 20005332 A NO20005332 A NO 20005332A NO 20005332 A NO20005332 A NO 20005332A NO 20005332 L NO20005332 L NO 20005332L
Authority
NO
Norway
Prior art keywords
glucopyranosyl
composition
mannite
sorbit
gpm
Prior art date
Application number
NO20005332A
Other languages
English (en)
Other versions
NO20005332D0 (no
Inventor
Markwart Kunz
Tillman Doerr
Bodo Fritzsching
Michael Klingeberg
Gunhild Kozianowski
Knut Martin Rapp
Joerg Kowalczyk
Peter J Straeter
Original Assignee
Suedzucker Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Suedzucker Ag filed Critical Suedzucker Ag
Publication of NO20005332D0 publication Critical patent/NO20005332D0/no
Publication of NO20005332L publication Critical patent/NO20005332L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/30—Zinc; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Pulmonology (AREA)
  • Virology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Saccharide Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Sorption Type Refrigeration Machines (AREA)
  • Thermotherapy And Cooling Therapy Devices (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

Foreliggende oppfinnelse angår anvendelsen av sukkeralkoholblandinger som terapeutisk aktive stoffer.
NO20005332A 1998-04-28 2000-10-23 1,6-GPS-(6-O-α-D-glukopyranosyl-D-sorbit) og 1,1-GPM-(1-O-α-D-glukopyranosyl-D-mannit)-holdig sukkeralkoholblanding for bruk som terapeutisk aktivt stoff samt legemiddel inneholdende nevnte blanding NO20005332L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19818842A DE19818842C1 (de) 1998-04-28 1998-04-28 Erkältungsmittel
US09/175,831 US6139864A (en) 1998-04-28 1998-10-20 Compositions for common colds
PCT/EP1999/002866 WO1999055342A1 (de) 1998-04-28 1999-04-28 Isomalt als wirkstoff enthaltendes erkältungsmittel

Publications (2)

Publication Number Publication Date
NO20005332D0 NO20005332D0 (no) 2000-10-23
NO20005332L true NO20005332L (no) 2000-12-22

Family

ID=26045798

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20005332A NO20005332L (no) 1998-04-28 2000-10-23 1,6-GPS-(6-O-α-D-glukopyranosyl-D-sorbit) og 1,1-GPM-(1-O-α-D-glukopyranosyl-D-mannit)-holdig sukkeralkoholblanding for bruk som terapeutisk aktivt stoff samt legemiddel inneholdende nevnte blanding

Country Status (19)

Country Link
US (1) US6139864A (no)
EP (1) EP1079839B1 (no)
JP (1) JP5053482B2 (no)
AT (1) ATE275404T1 (no)
AU (1) AU750373B2 (no)
BR (1) BRPI9910024B8 (no)
CA (1) CA2330563A1 (no)
DE (2) DE19818842C1 (no)
DK (1) DK1079839T3 (no)
ES (1) ES2228046T3 (no)
HU (1) HUP0101490A3 (no)
IL (1) IL139318A (no)
MX (1) MXPA00010598A (no)
NO (1) NO20005332L (no)
NZ (1) NZ508371A (no)
PT (1) PT1079839E (no)
RU (1) RU2216329C2 (no)
TR (1) TR200003156T2 (no)
WO (1) WO1999055342A1 (no)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10104055A1 (de) 2001-01-31 2002-08-14 Suedzucker Ag Verwendung von Kohlenhydraten zur Beseitigung von Darminfektionen bei Tieren
DE10130298A1 (de) 2001-06-22 2003-01-23 Nutrinova Gmbh Antimikrobiell wirksame Acesulfam-Komplexe, Verfahren zu ihrer Herstellung und ihre Verwendung
US20040052851A1 (en) * 2002-09-16 2004-03-18 Graff Allan H. Modified release oral dosage form
AU2003266159A1 (en) * 2002-09-16 2004-04-30 Zicam, Llc. System and method for delivering a composition to the nasal membrane
US20070092552A1 (en) * 2003-04-30 2007-04-26 Tim Clarot Chewable lozenge cold remedy composition and method for making same
US20070092583A1 (en) * 2003-04-30 2007-04-26 Tim Clarot Cold remedy composition comprising zinc salts
US7754763B2 (en) * 2003-04-30 2010-07-13 Zicam, Llc Oral composition to reduce cold symptoms and duration of same
DE10328180A1 (de) * 2003-06-16 2005-01-13 Südzucker AG Mannheim/Ochsenfurt Verwendung von Isomalt als Präbiotikum
US7968122B2 (en) * 2003-12-10 2011-06-28 Adventrx Pharmaceuticals, Inc. Anti-viral pharmaceutical compositions
EP1712139A1 (en) * 2005-04-15 2006-10-18 Cargill Incorporated Sustained energy release compositions
WO2007144943A1 (ja) * 2006-06-14 2007-12-21 House Wellness Foods Corporation 免疫機能増強組成物
WO2008137632A1 (en) * 2007-05-04 2008-11-13 The Procter & Gamble Company Antimicrobial compositions, products, and methods of use
DE102008012015A1 (de) 2008-03-01 2009-09-10 Südzucker AG Mannheim/Ochsenfurt Verbesserte Isomalt-haltige Komprimate und Verfahren zu ihrer Herstellung
JP5710111B2 (ja) * 2009-07-14 2015-04-30 株式会社ロッテ ラクチトール、マルチトールからなる抗菌剤
JP6039552B2 (ja) 2010-07-01 2016-12-07 グラクソ グループ リミテッドＧｌａｘｏ Ｇｒｏｕｐ Ｌｉｍｉｔｅｄ 高産生細胞株を選択するための改良された方法
WO2023105086A1 (en) * 2021-12-10 2023-06-15 Gudiminchi Rama Krishna Use of glycosylated sugar alcohols

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5002970A (en) * 1981-07-31 1991-03-26 Eby Iii George A Flavor masked ionizable zinc compositions for oral absorption
US5409905A (en) * 1981-01-05 1995-04-25 Eby, Iii; George A. Cure for commond cold
JPS6131057A (ja) * 1984-07-25 1986-02-13 Fuji Oil Co Ltd フィリング材
JPS6168487A (ja) * 1984-09-12 1986-04-08 Sumitomo Chem Co Ltd カルバモイルアゾール誘導体およびそれを有効成分とする除草剤
DE3826946C1 (no) * 1988-08-09 1990-03-15 A. Nattermann & Cie Gmbh, 5000 Koeln, De
JP2729820B2 (ja) * 1988-12-27 1998-03-18 昭和産業株式会社 免疫賦活剤
GB9010742D0 (en) * 1990-05-14 1990-07-04 Quadrant Bioresources Ltd Stabilization of biological macromolecular substances
JP3125888B2 (ja) * 1991-03-14 2001-01-22 三菱化学株式会社 エリスリトールを含有する飲料水
RU2061491C1 (ru) * 1993-02-04 1996-06-10 Николай Яковлевич Костеша Способ получения средства, повышающего резистентность организма
CA2102142A1 (en) * 1993-03-30 1994-10-01 Andrew J. Ghio Method of inhibiting oxidants using alkylaryl polyether alcohol polymers
DE59303142D1 (de) * 1993-05-06 1996-08-08 Suedzucker Ag Süssungsmittel, Verfahren zur Herstellung desselben sowie dessen Verwendung
DE9321600U1 (de) * 1993-05-06 2000-04-06 Südzucker Aktiengesellschaft Mannheim/Ochsenfurt, 68165 Mannheim Süssungsmittel
JP3611131B2 (ja) * 1994-06-30 2005-01-19 カネボウ株式会社 アスコルビン酸含有食品添加用糖衣物
EP0710484A3 (en) * 1994-10-07 1996-10-23 Univ Illinois Mixture of alpha-D-glucopyranosyl- (1-6) -alpha-D glucopyranose as an anti-tumor agent
JP3396129B2 (ja) * 1995-06-07 2003-04-14 武田食品工業株式会社 免疫賦活剤
JPH08333261A (ja) * 1995-06-09 1996-12-17 Teika Corp 抗ウイルス・菌剤
JP3837769B2 (ja) * 1995-06-12 2006-10-25 大塚製薬株式会社 抗ウイルス剤
DE19532396C2 (de) * 1995-09-02 1997-08-21 Suedzucker Ag Zuckerfreie Produkte und Verfahren zu ihrer Herstellung
DE19549825B4 (de) * 1995-09-02 2010-11-04 Südzucker AG Mannheim/Ochsenfurt Zuckerfreie Hartkaramellen
DE19606968C2 (de) * 1996-02-24 1998-07-09 Suedzucker Ag Verwendung von 1,1-GPS in Hartkaramellen
DE19639342C2 (de) * 1996-09-25 1998-07-16 Suedzucker Ag Kaugummi, enthaltend ein Süßungsmittel

Also Published As

Publication number Publication date
PT1079839E (pt) 2005-01-31
JP5053482B2 (ja) 2012-10-17
EP1079839A1 (de) 2001-03-07
BRPI9910024B8 (pt) 2021-05-25
JP2002512966A (ja) 2002-05-08
AU750373B2 (en) 2002-07-18
HUP0101490A2 (hu) 2001-08-28
IL139318A (en) 2005-12-18
BR9910024A (pt) 2000-12-26
WO1999055342A1 (de) 1999-11-04
ATE275404T1 (de) 2004-09-15
EP1079839B1 (de) 2004-09-08
DE59910457D1 (de) 2004-10-14
TR200003156T2 (tr) 2001-03-21
MXPA00010598A (es) 2002-04-24
BRPI9910024B1 (pt) 2015-09-01
CA2330563A1 (en) 1999-11-04
NO20005332D0 (no) 2000-10-23
DK1079839T3 (da) 2005-01-17
US6139864A (en) 2000-10-31
RU2216329C2 (ru) 2003-11-20
AU4034599A (en) 1999-11-16
IL139318A0 (en) 2001-11-25
HUP0101490A3 (en) 2003-07-28
ES2228046T3 (es) 2005-04-01
NZ508371A (en) 2002-09-27
DE19818842C1 (de) 2000-01-05

Similar Documents

Publication Publication Date Title
TR199900083T2 (xx) Klaritromisinin kristal bi�imi I.
TW200510375A (en) New compounds
HUP9601566A2 (en) Therapeutic tetrahydro-isoquinolin derivatives, their intermediates and pharmaceutical compositions containing the active component
DE69626660D1 (en) 2-alkylpyrrolidine
HUP0004421A3 (en) Urea derivatives and pharmaceutical compositions containing them, use thereof for the treatment of deseases mediated by impdh enzyme
CA2292984A1 (en) Ccr5 modulators
DK0886474T3 (da) Karameller indeholdende et sødemiddel
TR200002869T2 (tr) İkame edilmiş indolealkonik asitler.
MXPA02012272A (es) Compuestos heterociclicos que son inhibidores de la enzima dipeptidilpeptidasa-iv.
DE69940674D1 (de) Orale verabreichung von adenosin analogen
NO990789L (no) Cytotoksisk aminosukker og beslektede sukker-derivater av indolopyrrolokarbazoler
FR2707882B1 (fr) Nouveaux kits thérapeutiques anti-médiateurs protéiques, procédé de préparation et compositions pharmaceutiques les renfermant.
SG26364G (en) 2', 3'-dideoxy-3'-fluorothymidine and related compounds for the treatment of adenovirus infections
CA2330681A1 (en) Control of pain with endogenous cannabinoids
NO305903B1 (no) Benzonitriler og benzofluorider, legemidler bestående av forbindelsene, farmasöytiske preparater inneholdende forbindelsene, samt anvendelse av forbindelsene for fremstilling av farmasöytiske preparater
UA29466C2 (uk) Фармацевтична композиція з антипухлинною активністю
PT929234E (pt) Comprimidos contendo um edulcorante
NO980317L (no) Anvendelse av Calendula-glykosider for behandling av psoriasis
IL139318A0 (en) Sugar alcohol mixtures as therapeutic agents and pharmaceutical compositions containing the same
MX9403088A (es) Composiciones farmaceuticas que contienen deriva- dos de indol y metodos de uso.
WO1996022305A3 (en) Modified peptides
WO1996021468A3 (en) Chemically modified interferon
DK0773782T3 (da) Terpenderivater (sarcodictyiner) anvendelse som antitumormidler
MX9709453A (es) Composicion farmaceutica oral de compuestos de piperidinoalcanol en forma de solucion.
DK0934342T3 (da) Præparat indeholdende chitosan

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application